Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Platinum-induced DNA crosslinking is a critical molecular target exploited by several frontline chemotherapeutic agents. By forming covalent bonds predominantly at guanine residues within nuclear DNA, these drugs create structural distortions that inhibit vital genetic processes. The resulting cytotoxicity underpins their clinical utility against various cancers but also drives research into mechanisms underlying drug resistance and toxicity profiles.
Forms covalent adducts with DNA, primarily at guanine N7 positions, leading to intra- and interstrand crosslinks that distort DNA structure and inhibit replication/transcription.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA Crosslinking via Platinum–DNA Adducts.